Get your own Free Home Page
BIOLOGICAL MARKER STUDY IS PUBLISHED!
On Thursday, July 17, 1997, a study was published that identifies a possible biological marker for Chronic Fatigue Syndrome (CFS). Dr. Robert Suhadolnik, Ph.D., a professor of Biochemistry at Temple University School of Medicine in Philadelphia, published a paper, Biochemical Evidence for a Novel Low Molecular Weight 2-5A-Dependent RNase L in Chronic Fatigue Syndrome, in The Journal of Interferon and Cytokine Research, July 1997, 17:377-385.
Dr. Suhadolnik and his research team first described the discovery at a conference last October in San Francisco. The study shows a unique enzyme present in CFS patients that doesn't seem to appear in healthy control groups. Two other studies in Europe have confirmed Dr. Suhadolnik's discovery. His laboratory has been awarded research grants by The National Institutes of Health to study Chronic Fatigue Syndrome and AIDS. Dr. Suhadolnik and his research team are also beginning to investigate whether there might be therapies based on correcting the activity of the defective enzyme. He commented recently that he was greatly encouraged and that all the CFS patients that were tested, had the defective enzyme, while none of the healthy controls showed the enzyme.
Get your own Free Home Page